| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_562e4af016953c0a80e09960559ed0d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_30638c0ec23ce0b355d17622ab67eee1 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6876
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 |
| filingDate |
2005-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4abcc90a0cff24d8c4e4b240d1e93f09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09759f9c1e842598b0602e14b5ecfd89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e3870a6ef3fdeaf39e7a3be85af9cb0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b3bfa02a132dd9683117528be6b4c33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a6f28851e8790ee3025f9fa4bf196e3 |
| publicationDate |
2009-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2009099069-A1 |
| titleOfInvention |
Modulators of alpha-synuclein toxicity |
| abstract |
Disclosed are compositions and methods for modulating expression of genes that function at the step of ER of Golgi trafficking. Compounds that modulate expression of these genes of activity of the encoded proteins can be used to inhibit alpha-synuclein mediated toxicity and used to threat of prevent synucleinopathies such as Parkinson's disease. Also disclosed are methods of identifying inhibitors of alpha-synuclein mediated toxicity. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8735072-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012027713-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9909160-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9249444-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3736343-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9879257-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11047848-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9018003-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014275211-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011064722-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011041582-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011041584-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012027713-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009068111-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009304664-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022238974-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8133679-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8501465-B2 |
| priorityDate |
2004-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |